CURx Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • University Spin-Out

  • Investors
  • 1

CURx Pharmaceuticals General Information

Description

Operator of a pharmaceutical company intended to develop products that address unmet medical needs. The company licenses and commercializes therapeutic candidates for chronic disease, and also offfers formulation of Topiramate based on a licensing deal, enabling patients to have innovative and differentiated therapeutics that will improve their quality of life and clinical outcome.

Contact Information

Website
www.curxpharma.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CURx Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. University Spin-Out 01-Jan-2013 Completed Startup
To view CURx Pharmaceuticals’s complete valuation and funding history, request access »

CURx Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop products that address unmet medical needs. The company licenses
Pharmaceuticals
San Diego, CA

Karachi, Pakistan

Cerdanyola, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CURx Pharmaceuticals Competitors (22)

One of CURx Pharmaceuticals’s 22 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Pakistan Corporation Karachi, Pakistan
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Genentech Formerly VC-backed South San Francisco, CA
Pfizer (Vienna) Corporation Vienna, Austria
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 22 competitors. Get the full list »

CURx Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Minnesota University
To view CURx Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

CURx Pharmaceuticals FAQs

  • When was CURx Pharmaceuticals founded?

    CURx Pharmaceuticals was founded in 2013.

  • Where is CURx Pharmaceuticals headquartered?

    CURx Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is CURx Pharmaceuticals in?

    CURx Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is CURx Pharmaceuticals a private or public company?

    CURx Pharmaceuticals is a Private company.

  • What is CURx Pharmaceuticals’s current revenue?

    The current revenue for CURx Pharmaceuticals is .

  • Who are CURx Pharmaceuticals’s investors?

    University of Minnesota has invested in CURx Pharmaceuticals.

  • Who are CURx Pharmaceuticals’s competitors?

    Pfizer Pakistan, Ability Pharma, Genentech, Pfizer (Vienna), and Novartis are some of the 22 competitors of CURx Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process